Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has submitted a routine compliance certificate to BSE under SEBI's Regulation 74(5) for the quarter ended 30 September 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Satellite Corporate Services Private Limited. It confirms that physical share certificates received for dematerialization have been listed, verified, mutilated, and cancelled, with the depository recorded as the registered owner. Importantly, the registrar noted that no physical certificates were received for dematerialization during the quarter, meaning nothing material changed in the shareholding structure. The filing was signed by Director Babita on 8 October 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms standard housekeeping related to share dematerialization and does not indicate any corporate action, financial change, or business development.